FENNEC PHARMACEUTICALS INC. Quarterly Operating Margin in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Fennec Pharmaceuticals Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q2 2024.
  • Fennec Pharmaceuticals Inc. Operating Margin for the quarter ending June 30, 2024 was 12 %.
  • Fennec Pharmaceuticals Inc. annual Operating Margin for 2023 was -60.1 %, a 95.9% increase from 2022.
  • Fennec Pharmaceuticals Inc. annual Operating Margin for 2022 was -1.47K %.
Operating Margin, Quarterly (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 12 Apr 1, 2024 Jun 30, 2024
Q1 2024 13.9 Jan 1, 2024 Mar 31, 2024
Q4 2023 -60.1 Oct 1, 2023 Dec 31, 2023
Q1 2021 -9.49K Jan 1, 2021 Mar 31, 2021
Q4 2020 -8.94K Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.